Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Diphenhydramine recalled?

Yes — there is an active recall. 8 ongoing FDA recalls mention Diphenhydramine (49 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Diphenhydramine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Diphenhydramine recalls on record

none so far in 2026; 49 on record, newest first
Class II · Moderate risk

Allergy Liquid Antihistamine

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc D-1347-2019
Class II · Moderate risk

Diphenhydramine HCl USP f

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8081-4 D-0485-2018
Class II · Moderate risk

Doctor Manzanilla Cough & Cold

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Terminated Microbial contamination Mid Valley Pharmaceutical D-1136-2017
Class I · High risk

Mucinex Fast Max Night Time Cold & Flu

Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.

Terminated Labeling / mix-up Reckitt Benckiser LLC NDC 63824-500-66 D-1364-2015
Class II · Moderate risk

Diphenhydramine

Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.

Terminated Chemical / undeclared Brookfield Prescription Center Inc. dba MD Custom Rx D-1417-2014
Class III · Low risk

Advil PM Caplets

Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.

Terminated Wrong potency / content Pfizer Us Pharmaceutical Group NDC 0573-0164-43 D-1166-2014
Class II · Moderate risk

diphenhydrAMINE HCl

Labeling: Label Mixup; diphenhydrAMINE HCl, Tablet, 25 mg may be potentially mislabeled as ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: AD33897_10, EXP: 5/9/2014; ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W002774, EXP: 6/6/2014; PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003511, EXP: 6/21/2014; VENLAFAXINE, Tablet, 25 mg

Terminated Labeling / mix-up Aidapak Services, LLC D-483-2014
Class II · Moderate risk

Pure-Aid Allergy Relief

Labeling: Not Elsewhere Classified; foil label on immediate blister pack indicates active ingredient as Chlorpheniramine rather than Diphenhydramine

Terminated Labeling / mix-up Kareway Product Inc D-620-2013
Class II · Moderate risk

Diphenhydramine 25mg/Ml Injectable 90 Ml

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1503-2012